| Financial Year |
March 31 2023 |
| Monetary Funds |
177,062,251.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
50,742,505.83 |
| Accounts Receivable |
301,628,218.82 |
| Advances to Suppliers |
2,543,935.03 |
| Other Receivables |
7,033,238.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
298,825,628.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,861,462.84 |
| Total Current Assets |
864,897,736.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
287,971,515.67 |
| Under-construction Projects |
31,973,626.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,790,357.12 |
| R&D expenses |
-- |
| Goodwill |
10,008,329.39 |
| Long-Term Deferred and Prepaid Expenses |
3,586,002.66 |
| Deferred Income Tax Assets |
22,623,651.85 |
| Other Non-Current Assets |
5,007,999.31 |
| Sub-Total of Non-Current Assets |
439,114,698.89 |
| Total Assets |
1,304,012,434.95 |
| Short-Term Loans |
119,155,925.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,989,224.61 |
| Accounts Payable |
312,837,476.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,744,338.74 |
| Taxes Payable |
2,316,879.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,041,115.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,248,537.80 |
| Other Current Liabilities |
38,068.93 |
| Sub-Total of Current Liabilities |
601,830,672.90 |
| Long-term Loans |
104,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,521.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
106,395,965.75 |
| Total Liabilities |
708,226,638.65 |
| Paid-In Capital(Or Share Stock) |
366,120,000.00 |
| Capital Surplus |
34,662,391.61 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
34,210,800.00 |
| Undistributed Profits |
223,316,287.07 |
| Minority Stockholder's Interest |
5,833,479.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
589,952,316.47 |
| Owner's Equity（Stockholder's Equity） |
595,785,796.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,304,012,434.95 |
